← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1989Last known activity
Jan 31, 2026
Timeline
1980s
- Jan 1, 1980
Canadian Cancer Trials Group— Founded
Drugs by trial phase (194 distinct, 268 trials)
Phase 3 (114 own, 0 via acquisition)
Phase 2 (72 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma of Lung
- Adenomyoepithelioma
- Adenoviridae Infections
- Anemia
- Anorexia
- Bile Duct Neoplasms
- Bone Marrow Diseases
- Bone Neoplasms
- Brain Neoplasms
- Breast Neoplasms
- Cachexia
- Cancer Pain
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Cystadenocarcinoma, Serous
- Deglutition Disorders
- Drug-Related Side Effects and Adverse Reactions
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Gallbladder Neoplasms
- Gastrointestinal Stromal Tumors
- Germinoma
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Hodgkin Disease
- Infections
- Inflammatory Breast Neoplasms
- Intestinal Neoplasms
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell, Peripheral
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuroblastoma
- Neutropenia
- Oligodendroglioma
- Oropharyngeal Neoplasms
- Osteoporosis
- Ovarian Neoplasms
- Pancoast Syndrome
- Pancreatic Neoplasms
- Parasomnias
- Peritoneal Neoplasms
- Pheochromocytoma
- Plasmacytoma
- Precancerous Conditions
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Intraepithelial Neoplasia
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Salivary Gland Neoplasms
- Sarcoma
- Sleep Wake Disorders
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Syndrome
- Triple Negative Breast Neoplasms
- Ulcer
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Uterine Cervical Neoplasms
- Vomiting
Recent trials (50)
- NCT07297667Lead sponsorPhase 1Jan 31, 2026
- NCT06809322CollaboratorPhase 3Dec 5, 2025
- NCT07237256CollaboratorPhase 3Dec 1, 2025
- NCT07152821Lead sponsorPhase 3Nov 30, 2025
- NCT06880523Lead sponsorPhase 2Oct 21, 2025
- NCT06592924Lead sponsorPhase 3Jan 15, 2025
- NCT06623461Lead sponsorPhase 2Dec 31, 2024
- NCT06439225Lead sponsorPhase 3Nov 30, 2024
- NCT06205485Lead sponsorPhase 3Jun 26, 2024
- NCT05773274Overall official - principal investigatorPhase 2Mar 1, 2024
- NCT06182774Lead sponsorPhase 3Feb 28, 2024
- NCT06043427Lead sponsorPhase 2Jan 15, 2024
- NCT05998642Lead sponsorPhase 2Nov 30, 2023
- NCT05714891Lead sponsorPhase 2Sep 15, 2023
- NCT05743777Lead sponsorPhase 2May 12, 2023
Details
- Founded
- Kingston, CA Jan 1, 1980
- Last known activity
- Jan 31, 2026
Notes
CCTG’s Central Operations and Statistics Office is located in the Cancer Research Institute at Queen’s University